Cholesterol screening and management in children and young adults should start early--NO!

Prevalence of dyslipidaemia and associated risk factors among Balearic Islands adolescents, a Mediterranean region. Eur J Clin Nutr (2014) 0.77

A systematic review and meta-analysis on screening lipid disorders in the pediatric age group. J Res Med Sci (2015) 0.77

Does true Gleason pattern 3 merit its cancer descriptor? Nat Rev Urol (2016) 0.76

Serum Lipid Profile, Prevalence of Dyslipidaemia, and Associated Risk Factors Among Northern Mexican Adolescents. J Pediatr Gastroenterol Nutr (2016) 0.75

Low diagnostic yield of elective coronary angiography. N Engl J Med (2010) 9.38

ACCF/ACR/SCCT/SCMR/ASNC/NASCI/SCAI/SIR 2006 appropriateness criteria for cardiac computed tomography and cardiac magnetic resonance imaging: a report of the American College of Cardiology Foundation Quality Strategic Directions Committee Appropriateness Criteria Working Group, American College of Radiology, Society of Cardiovascular Computed Tomography, Society for Cardiovascular Magnetic Resonance, American Society of Nuclear Cardiology, North American Society for Cardiac Imaging, Society for Cardiovascular Angiography and Interventions, and Society of Interventional Radiology. J Am Coll Cardiol (2006) 7.77

ACCF/AHA 2007 clinical expert consensus document on coronary artery calcium scoring by computed tomography in global cardiovascular risk assessment and in evaluation of patients with chest pain: a report of the American College of Cardiology Foundation Clinical Expert Consensus Task Force (ACCF/AHA Writing Committee to Update the 2000 Expert Consensus Document on Electron Beam Computed Tomography) developed in collaboration with the Society of Atherosclerosis Imaging and Prevention and the Society of Cardiovascular Computed Tomography. J Am Coll Cardiol (2007) 5.40

ACCF/AHA 2007 clinical expert consensus document on coronary artery calcium scoring by computed tomography in global cardiovascular risk assessment and in evaluation of patients with chest pain: a report of the American College of Cardiology Foundation Clinical Expert Consensus Task Force (ACCF/AHA Writing Committee to Update the 2000 Expert Consensus Document on Electron Beam Computed Tomography). Circulation (2007) 4.66

Evidence-based guidelines for cardiovascular disease prevention in women: 2007 update. Circulation (2007) 4.16

Ability of exercise testing to predict cardiovascular and all-cause death in asymptomatic women: a 20-year follow-up of the lipid research clinics prevalence study. JAMA (2003) 3.64

Frequency of stress testing to document ischemia prior to elective percutaneous coronary intervention. JAMA (2008) 3.62

The prognostic value of normal exercise myocardial perfusion imaging and exercise echocardiography: a meta-analysis. J Am Coll Cardiol (2006) 2.64

Mandatory anesthesia. JAMA Intern Med (2013) 2.62

Strength of study evidence examined by the FDA in premarket approval of cardiovascular devices. JAMA (2009) 2.55

Medical devices--balancing regulation and innovation. N Engl J Med (2011) 2.45

Variations between clinical trial participants and Medicare beneficiaries in evidence used for Medicare national coverage decisions. Arch Intern Med (2008) 2.43

Cardiologists' use of percutaneous coronary interventions for stable coronary artery disease. Arch Intern Med (2007) 2.02

Role of noninvasive testing in the clinical evaluation of women with suspected coronary artery disease: Consensus statement from the Cardiac Imaging Committee, Council on Clinical Cardiology, and the Cardiovascular Imaging and Intervention Committee, Council on Cardiovascular Radiology and Intervention, American Heart Association. Circulation (2005) 1.97

Sex differences in major bleeding with glycoprotein IIb/IIIa inhibitors: results from the CRUSADE (Can Rapid risk stratification of Unstable angina patients Suppress ADverse outcomes with Early implementation of the ACC/AHA guidelines) initiative. Circulation (2006) 1.93

Accelerated approval and possible withdrawal of midodrine. JAMA (2010) 1.88

Patterns and intensity of medical therapy in patients undergoing percutaneous coronary intervention. JAMA (2011) 1.88

Low rate of sex-specific result reporting in cardiovascular trials. Mayo Clin Proc (2007) 1.84

ACC/AHA key data elements and definitions for measuring the clinical management and outcomes of patients with chronic heart failure: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Data Standards (Writing Committee to Develop Heart Failure Clinical Data Standards): developed in collaboration with the American College of Chest Physicians and the International Society for Heart and Lung Transplantation: endorsed by the Heart Failure Society of America. Circulation (2005) 1.78

Coronary CT angiography for acute chest pain. N Engl J Med (2012) 1.78

Less is more: how less health care can result in better health. Arch Intern Med (2010) 1.77

Evidence-based guidelines for cardiovascular disease prevention in women: 2007 update. J Am Coll Cardiol (2007) 1.69

Role of noninvasive testing in the clinical evaluation of women with suspected ischemic heart disease: a consensus statement from the American Heart Association. Circulation (2014) 1.67

Disparities in use of implantable cardioverter-defibrillators: moving beyond process measures to outcomes data. JAMA (2007) 1.66

Gender bias in studies for Food and Drug Administration premarket approval of cardiovascular devices. Circ Cardiovasc Qual Outcomes (2011) 1.61

CMS's landmark decision on CT colonography--examining the relevant data. N Engl J Med (2009) 1.61

AHA/ACCF [corrected] 2009 performance measures for primary prevention of cardiovascular disease in adults: a report of the American College of Cardiology Foundation/American Heart Association task force on performance measures (writing committee to develop performance measures for primary prevention of cardiovascular disease): developed in collaboration with the American Academy of Family Physicians; American Association of Cardiovascular and Pulmonary Rehabilitation; and Preventive Cardiovascular Nurses Association: endorsed by the American College of Preventive Medicine, American College of Sports Medicine, and Society for Women's Health Research. Circulation (2009) 1.54

Choosing wisely in pediatric hospital medicine: five opportunities for improved healthcare value. J Hosp Med (2013) 1.52

Hospital course and discharge criteria for children hospitalized with bronchiolitis. J Hosp Med (2015) 1.46

ACC/AHA key data elements and definitions for measuring the clinical management and outcomes of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Data Standards (Writing Committee to Develop Data Standards on Atrial Fibrillation). Circulation (2004) 1.45

Noninvasive cardiac imaging. Am Fam Physician (2007) 1.45

Evidence of pharmaceutical innovation and therapeutic enthusiasm: strategies for patent extension. Arch Intern Med (2012) 1.43

Reconsidering transfer for percutaneous coronary intervention strategy: time is of the essence. Arch Intern Med (2011) 1.42

Mortality in Medicare patients undergoing elective percutaneous coronary intervention with or without antecedent stress testing. Circ Cardiovasc Qual Outcomes (2013) 1.41

Coronary artery calcium: should we rely on this surrogate marker? Circulation (2006) 1.40

First physical. Arch Intern Med (2010) 1.39

The 510(k) ancestry of a metal-on-metal hip implant. N Engl J Med (2013) 1.36

Editor's Note--to make the case--evidence is required: comment on "Making the case for selective use of statins in the primary prevention setting". Arch Intern Med (2011) 1.33

ACC/AHA/HRS 2006 key data elements and definitions for electrophysiological studies and procedures: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Data Standards (ACC/AHA/HRS Writing Committee to Develop Data Standards on Electrophysiology). Circulation (2006) 1.29

Inclusion of comparative effectiveness data in high-risk cardiovascular device studies at the time of premarket approval. JAMA (2012) 1.26

Presumed safe no more: lessons from the Wingspan saga on regulation of devices. BMJ (2014) 1.23

A systematic review of gender differences in mortality after coronary artery bypass graft surgery and percutaneous coronary interventions. Clin Cardiol (2007) 1.16

ACCF/AHA 2009 performance measures for primary prevention of cardiovascular disease in adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Performance Measures (Writing Committee to Develop Performance Measures for Primary Prevention of Cardiovascular Disease) developed in collaboration with the American Academy of Family Physicians; American Association of Cardiovascular and Pulmonary Rehabilitation; and Preventive Cardiovascular Nurses Association: endorsed by the American College of Preventive Medicine, American College of Sports Medicine, and Society for Women's Health Research. J Am Coll Cardiol (2009) 1.16

Premarket approval supplement pathway: do we know what we are getting? Ann Intern Med (2014) 1.14

Exercise blood pressure and future cardiovascular death in asymptomatic individuals. Circulation (2010) 1.11

Enhanced risk assessment in asymptomatic individuals with exercise testing and Framingham risk scores. Circulation (2005) 1.10

Relation of increased prebeta-1 high-density lipoprotein levels to risk of coronary heart disease. Am J Cardiol (2011) 1.09

Cancer risks and radiation exposure from computed tomographic scans: how can we be sure that the benefits outweigh the risks? Arch Intern Med (2009) 1.07

ACC/AHA key data elements and definitions for measuring the clinical management and outcomes of patients with atrial fibrillation: A report of the American College of Cardiology/American Heart Association Task Force on Clinical Data Standards (Writing Commitee to Develop Data Standards on Atrial Fibrillation). J Am Coll Cardiol (2004) 1.07

Prolonged infusion of dexmedetomidine for sedation following tracheal resection. Paediatr Anaesth (2005) 1.05

ACC/AHA/HRS 2006 key data elements and definitions for electrophysiological studies and procedures: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Data Standards (ACC/AHA/HRS Writing Committee to Develop Data Standards on Electrophysiology). J Am Coll Cardiol (2006) 1.05

Screening asymptomatic diabetic patients for coronary artery disease: why not? J Am Coll Cardiol (2006) 1.04

Approaches to enhancing radiation safety in cardiovascular imaging: a scientific statement from the American Heart Association. Circulation (2014) 1.04

Why physicians favor use of percutaneous coronary intervention to medical therapy: a focus group study. J Gen Intern Med (2008) 1.01

Women's Ischemic Syndrome Evaluation: current status and future research directions: report of the National Heart, Lung and Blood Institute workshop: October 2-4, 2002: executive summary. Circulation (2004) 0.98

On Chlorofluorocarbon Bans and Inhaled Albuterol Prices. JAMA Intern Med (2015) 0.96

Evolocumab in Patients with Cardiovascular Disease. N Engl J Med (2017) 0.95

Prevention Conference VI: Diabetes and Cardiovascular Disease: Writing Group III: risk assessment in persons with diabetes. Circulation (2002) 0.92

The harm in looking. JAMA Pediatr (2013) 0.91

Evaluating sex differences in medical device clinical trials: time for action. JAMA (2012) 0.89

ACC/AHA 2007 methodology for the development of clinical data standards: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Data Standards. J Am Coll Cardiol (2007) 0.89

The appropriateness imperative. Am Heart J (2007) 0.89

Less is more. Arch Intern Med (2010) 0.88

Fever literacy and fever phobia. Clin Pediatr (Phila) (2013) 0.88

Vitamin E and cardiovascular health: does sex matter? JAMA (2005) 0.88

The high price of the new hepatitis C virus drugs. JAMA Intern Med (2014) 0.87

Risk refinement, reclassification, and treatment thresholds in primary prevention of cardiovascular disease: incremental progress but significant gaps remain. Arch Intern Med (2010) 0.87

Inclusion of training patients in US Food and Drug Administration premarket approval cardiovascular device studies. Arch Intern Med (2010) 0.87

The beginning of a new era for the Archives and the nation. Arch Intern Med (2009) 0.86

Impact of changes in clinical practice guidelines on assessment of quality of care. Med Care (2010) 0.85

A review of the relationships between endogenous sex steroids and incident ischemic stroke and coronary heart disease events. Curr Cardiol Rev (2015) 0.85

The role of sex-specific results reporting in cardiovascular disease. Cardiol Rev (2007) 0.85

Improving the quality of care for women with cardiovascular disease: report of a DCRI Think Tank, March 8 to 9, 2007. Am Heart J (2008) 0.84

Time for professional societies to be bold and wise. JAMA Intern Med (2015) 0.84

Dispelling the myths: calling for sex-specific reporting of trial results. Mayo Clin Proc (2008) 0.84

A national interactive web-based physical activity intervention in women, evaluation of the american heart association choose to move program 2006-2007. Am J Cardiol (2012) 0.83

Women's Ischemic Syndrome Evaluation: current status and future research directions: report of the National Heart, Lung and Blood Institute workshop: October 2-4, 2002: Section 2: stable ischemia: pathophysiology and gender differences. Circulation (2004) 0.83

Stress testing in the emergency department: not which test but whether any test should be done. JAMA Intern Med (2015) 0.82

Associations between respiratory illnesses and secondhand smoke exposure in flight attendants: A cross-sectional analysis of the Flight Attendant Medical Research Institute Survey. Environ Health (2011) 0.82

Partnering to reduce risks and improve cardiovascular outcomes: American Heart Association initiatives in action for consumers and patients. Circulation (2009) 0.82

Gender, race, and cardiac care: why the differences? J Am Coll Cardiol (2005) 0.81

Statins and weight gain. JAMA Intern Med (2014) 0.81

Health benefits of sauna bathing. JAMA Intern Med (2015) 0.81

Remote second-hand tobacco exposure in flight attendants is associated with systemic but not pulmonary hypertension. Cardiol J (2008) 0.81

Recollection of pain due to inappropriate versus appropriate implantable cardioverter-defibrillator shocks. Pacing Clin Electrophysiol (2010) 0.81

Effect of intracoronary estradiol on postischemic microvascular damage in a porcine model: a myocardial contrast echocardiographic study. Angiology (2003) 0.80

Medical device regulation: time to improve performance. PLoS Med (2012) 0.80

Developing methods for less is more. JAMA Intern Med (2014) 0.80

High prevalence of cardiometabolic risk factors in women considered low risk by traditional risk assessment. J Womens Health (Larchmt) (2008) 0.79

Acute coronary syndromes in women: is treatment different? Should it be? Curr Cardiol Rep (2004) 0.79

The role of post-acute care in variation in the Medicare program. JAMA Intern Med (2015) 0.79

Gender and valvular surgery. J Thorac Cardiovasc Surg (2004) 0.79

The need for sex-specific data prior to food and drug administration approval. J Am Coll Cardiol (2010) 0.79

Utility of clinical and radiographic findings in the management of traumatic epidural hematoma. Pediatr Neurosurg (2014) 0.78

Is what is good for the gander really good for the goose? Arch Intern Med (2009) 0.78

Transcatheter aortic-valve replacement. N Engl J Med (2011) 0.78

ACC 2009 Advocacy Position Statement: Principles for comparative effectiveness research. J Am Coll Cardiol (2009) 0.78

Cardiovascular disease in women. Expert Rev Cardiovasc Ther (2010) 0.78

Clinical trial enrollment and progress in women's health. JAMA (2011) 0.78